Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$96.34 - $112.38 $2.95 Million - $3.44 Million
30,600 Added 5.15%
624,500 $64.2 Million
Q1 2023

Apr 28, 2023

SELL
$107.32 - $113.5 $321,960 - $340,500
-3,000 Reduced 0.5%
593,900 $64.8 Million
Q4 2022

Feb 09, 2023

BUY
$62.39 - $113.8 $37.2 Million - $67.9 Million
596,900 New
596,900 $67.9 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Polaris Capital Management, LLC Portfolio

Follow Polaris Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Capital Management, LLC with notifications on news.